Cardiovascular Diseases Clinical Trial
Official title:
Relation of Diet to Serum Homocysteine Level in Youths
To examine the relation between diet and plasma total homocysteine levels in an ethnically and geographically diverse cohort of adolescents.
BACKGROUND:
Data from observational studies suggest that plasma total homocysteine (tHcy) concentration
may be an independent and modifiable risk factor for cardiovascular disease (CVD) in adults.
Plasma tHcy levels respond rapidly to nutrient supplementation with folic acid and vitamins
Bl2 and B6, alone or in combination. The available data and the potential for prevention
provide a strong rationale for understanding determinants of tHcy in youth. However, no
large U.S. studies have examined the relation between tHcy levels to individuals' dietary
intakes of folic acid and vitamins Bl2 and B6 in youth.
DESIGN NARRATIVE:
During the Child and Adolescent Trial for Cardiovascular Health (CATCH) Phase 3, a
cross-sectional study of serum tHcy levels was conducted in eighth grade students (Jan-June
1997). Higher mean levels of plasma total homocysteine were observed among males, Blacks,
and non-users of multi-vitamins and a strong, inverse association with serum levels of folic
acid and to a lesser extent, with serum vitamin Bl2. A second measurement of the cohort at
grade 12 was conducted in order to assess the dose-response relation between serum tHcy and
dietary intakes (not measured in grade 8) of folic acid, vitamin B12 and vitamin B6. In
addition and of equal importance, changes were evaluated in serum folic acid and tHcy levels
from grade 8 to 12, after full implementation of fortification of cereal and grain products
in the U.S. with folic acid and its impact on the distribution of tHcy levels in adolescents
described. Effective January 1, 1998, the U.S. Department of Agriculture mandated the
addition of folic acid to all flour and grain products in the United States. CATCH had a
unique opportunity to examine the effect of "this natural experiment" on the distribution of
serum tHcy in the cohort, because serum tHcy levels were measured in grade 8, just prior to
full implementation of the mandate. Furthermore, the study had adequate sample size to
examine these changes among important demographic subgroups such as, males vs. females and
Caucasians vs. African Americans vs. Hispanics. Information generated by this study will be
valuable for designing specific dietary interventions for youth and targeting subgroups of
children who may be at higher risk for CVD.
;
Observational Model: Cohort, Time Perspective: Prospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|